• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射治疗期间肿瘤消退情况作为早期声门癌预后因素的临床评估

Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.

作者信息

Inoue T, Inoue T, Ikeda H, Teshima T, Murayama S

机构信息

Department of Radiology, Osaka Teishin Hospital, Japan.

出版信息

Strahlenther Onkol. 1992 Oct;168(10):579-83.

PMID:1440229
Abstract

From 1967 through 1985, 358 cases of early glottic carcinoma were treated with telecobalt therapy at the Department of Radiology, Osaka University Medical School. Among 278 cases treated with 2 Gy a day, the tumor response of 262 cases at 40, 50 and 60 Gy were evaluated by direct or indirect laryngoscope. The five-year local control rates of these evaluable cases of T1 and T2 glottic carcinoma were 79% and 70%, respectively. The local control rates of T1 glottic carcinoma with tumor clearance and persistence at 40 Gy were 83% (119/143) and 64% (43/67), and those of T2 cases were 86% (18/21) and 58% (18/31), respectively. The local control rates of the cases with tumor clearance and persistence at 40 Gy were same between T1 and T2 cases. The tumor clearance rates of T1 cases were significantly higher than those of T2 cases (p < 0.005). T2 glottic carcinoma had larger tumor volumes and slower tumor regression and resulted in lower control rates compared with T1 glottic carcinoma. The difference in the radiation dose of T1 and T2 glottic carcinoma with the same clearance rate was estimated as 15 Gy using logit analysis.

摘要

1967年至1985年期间,大阪大学医学院放射科采用远距离钴治疗法治疗了358例早期声门癌。在每天接受2 Gy治疗的278例患者中,通过直接或间接喉镜对262例患者在40、50和60 Gy时的肿瘤反应进行了评估。这些可评估的T1和T2声门癌病例的五年局部控制率分别为79%和70%。40 Gy时肿瘤清除和持续存在的T1声门癌局部控制率分别为83%(119/143)和64%(43/67),T2病例的局部控制率分别为86%(18/21)和58%(18/31)。40 Gy时肿瘤清除和持续存在的病例中,T1和T2病例的局部控制率相同。T1病例的肿瘤清除率显著高于T2病例(p < 0.005)。与T1声门癌相比,T2声门癌肿瘤体积更大,肿瘤消退更慢,导致控制率更低。使用logit分析估计,具有相同清除率的T1和T2声门癌的放射剂量差异为15 Gy。

相似文献

1
Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.放射治疗期间肿瘤消退情况作为早期声门癌预后因素的临床评估
Strahlenther Onkol. 1992 Oct;168(10):579-83.
2
Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.常规分割放疗治疗早期声门癌和声门上癌的比较
Strahlenther Onkol. 1993 Oct;169(10):584-9.
3
Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.T1期声门癌采用每天2Gy剂量进行远距离钴治疗的总时间。
Strahlenther Onkol. 1995 Aug;171(8):475-7.
4
Late local recurrence after radiotherapy for tongue and early glottic carcinoma.舌癌和早期声门癌放疗后的局部晚期复发
Strahlenther Onkol. 1996 Jun;172(6):301-5.
5
Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.T1期声门癌患者治疗前血红蛋白水平的意义
Radiat Oncol Investig. 1999;7(1):42-8. doi: 10.1002/(SICI)1520-6823(1999)7:1<42::AID-ROI6>3.0.CO;2-W.
6
Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.T1a和T1bN0M0期声门癌放疗的长期结果
Laryngoscope. 2008 Aug;118(8):1417-21. doi: 10.1097/MLG.0b013e3181781791.
7
Radiation therapy for larynx carcinoma: long-term results of stage I glottic carcinoma.喉癌的放射治疗:I 期声门癌的长期结果
Strahlenther Onkol. 1993 Feb;169(2):102-6.
8
Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.T1、2期声门癌的超分割加速放疗。时间剂量因素的考量。
Strahlenther Onkol. 2008 Jul;184(7):364-9. doi: 10.1007/s00066-008-1819-1. Epub 2008 Oct 1.
9
Role of radiotherapy in early glottic carcinoma.放疗在早期声门型喉癌中的作用。
Head Neck. 2010 Jul;32(7):850-9. doi: 10.1002/hed.21262.
10
Prognostic factor of telecobalt therapy for early glottic carcinoma.
Cancer. 1992 Dec 15;70(12):2797-801. doi: 10.1002/1097-0142(19921215)70:12<2797::aid-cncr2820701212>3.0.co;2-5.